– Gedeon Richter:La cariprazina tiene posibilidades reales de convertirse en el fármaco antipsicótico atípico más vendido BUDAPEST, Hungría, 10 de abril de 2024 /PRNewswire/ — Cariprazina, un fármaco antipsicótico original desarrollado por la empresa farmacéutica húngara Gedeon Richter…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.